Evaluation of the Safety and Immunogenicity of the Influenza Vaccine GSK2186877A in the Elderly
Clinical trial NCT00772889 · COMPLETED
Trial details
- NCT number
- NCT00772889
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2008-10-09
- Primary completion
- 2009-12-15
- Enrollment
- 971
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.